Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.-Reference-Cited by-同舟云学术

Expanded Access Programs, compassionate drug use, and Emergency Use Authorizations during the COVID-19 pandemic.

Published:2021-02 Issue:2 Volume:26 Page:593-603
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Rizk John G.^ORCID,Forthal Donald N.,Kalantar-Zadeh Kamyar,Mehra Mandeep R.,Lavie Carl J.,Rizk Youssef^ORCID,Pfeiffer JoAnn P.,Lewin John C.

Funder

Abbott

Abbvie

ACI Clinical

Akebia

Alexion

Amgen

Ardelyx

ASN

Astra-Zeneca

Aveo

BBraun

Chugai

Cytokinetics

Daiichi

DaVita

Fresenius

Genentech

Haymarket Media

Hofstra Medical School

IFKF

ISH

ISRNM

JSDT

Hospira

Kabi

Keryx

Kissei

Novartis

OPKO

NIH

National Kidney Foundations

Pfizer

Regulus

Relypsa

Resverlogix

Dr Schaer

Sandoz

Sanofi

Shire

Veterans’ Affairs

Vifor

UpToDate

ZS-Pharma

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference57 articles.

1. Evolution of the COVID-19 vaccine development landscape;Le;Nat. Revi. Drug Discovery,2020

2. FDA. How FDA Is Responding to COVID-19 Pandemic. www.fda.gov/media/140595/download. [Accessed 23 November 2020].

3. Overview of FDA’s Expanded Access Program for Investigational Drugs;Jarow;Ther. Innovation Regul. Sci.,2017

4. Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits;Fountzilas;Expert Opin. Invest. Drugs,2018

5. Expanded Access Programme: looking for a common definition;Iudicello;Trials,2016

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Equity and Access to COVID-19 Treatments Available through Emergency Use Authorizations;Journal of Racial and Ethnic Health Disparities;2024-07-22

2. Innovation through Artificial Intelligence in Triage Systems for Resource Optimization in Future Pandemics;Biomimetics;2024-07-18

3. Evaluation of a pharmacist-led workflow for the FDA Expanded Access Program;American Journal of Health-System Pharmacy;2024-03-25

4. Regulatory processes involved in clinical trials and intellectual property rights around vaccine development;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

5. Safety of COVID‐19 convalescent plasma: A definitive systematic review and meta‐analysis of randomized controlled trials;Transfusion;2023-12-29